These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9612901)

  • 1. [Cholestasis assessment by activity of antioxidant enzymes and composition of plasma lipoproteins in patients with liver diseases].
    Loginov AS; Matiushin BN; Chebanov SM; Reshetniak VI
    Ter Arkh; 1998; 70(4):40-2. PubMed ID: 9612901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A new approach to the diagnosis of cholestasis by the activity of copper-containing enzymes].
    Loginov AS; Matiushin BN; Tkachev VD; Iakimchuk GN
    Ter Arkh; 1993; 65(2):34-6. PubMed ID: 9133006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oxidative stress on antioxidant enzyme activities, homocysteine and lipoproteins in chronic kidney disease.
    Atamer A; Kocyigit Y; Ecder SA; Selek S; Ilhan N; Ecder T; Atamer Y
    J Nephrol; 2008; 21(6):924-30. PubMed ID: 19034878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of gamma-glutamyltransferase with plasma lipoprotein and lipid-protein complex in cholestasis.
    Watanabe M; Taketa K; Izumi M; Nagashima H
    Hepatogastroenterology; 1984 Oct; 31(5):204-7. PubMed ID: 6150887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of serum lipoproteid-X (LP-X) determination for the diagnosis of cholestasis in chronic liver diseases.
    Milewski B; Palynyczko Z
    Pol Med Sci Hist Bull (1973); 1975; 15(5-6):551-5. PubMed ID: 1228704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copper and zinc concentrations and the activities of ceruloplasmin and superoxide dismutase in atherosclerosis obliterans.
    Iskra M; Majewski W
    Biol Trace Elem Res; 2000 Jan; 73(1):55-65. PubMed ID: 10949969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lipoprotein X in hepatobiliary diseases].
    Mordasini RC; Berthold S; Schlumpf E; Keller H; Riva G
    Schweiz Med Wochenschr; 1975 Jul; 105(27):863-72. PubMed ID: 2969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of the superoxide dismutase activity in puncture biopsy specimens of the liver in chronic liver diseases].
    Matiushin BN; Loginov AS; Tkachev VD
    Lab Delo; 1991; (7):16-9. PubMed ID: 1724027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative determination of the abnormal lipoprotein of cholestasis, LP-X, in liver disease.
    Ritland S
    Scand J Gastroenterol; 1975; 10(1):5-15. PubMed ID: 164686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal lipoproteins in a case of primary biliary cirrhosis.
    Etienne J; Beucler I; Ayrault M; Cloarec M; Polonovski J; Debray J
    Biomedicine; 1978 Feb; 29(1):33-7. PubMed ID: 208677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A long-term follow-up study of the hepatic copper and serum ceruloplasmin concentrations in patients with chronic liver disease.
    Ritland S; Skrede S; Johansen O
    Scand J Gastroenterol; 1982 Jun; 17(4):545-51. PubMed ID: 7134882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of serum HCV core concentration with blood level of lipid and antioxidants in various forms of liver diseases.
    Irshad M; Dhar I; Gupta S; Khushboo ; Joshi YK
    Hepatogastroenterology; 2007; 54(75):898-902. PubMed ID: 17591087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The serum lipoprotein X (LP-X) test in the diagnosis of cholestatic hepatopathies (preliminary note)].
    Colalongo G; Nubile G; Fiorentini GP; Tabacchi L; Beltrandi E
    Boll Soc Ital Biol Sper; 1974 Sep; 50(18):1440-5. PubMed ID: 4458730
    [No Abstract]   [Full Text] [Related]  

  • 14. Ceruloplasmin copper induces oxidant damage by a redox process utilizing cell-derived superoxide as reductant.
    Mukhopadhyay CK; Fox PL
    Biochemistry; 1998 Oct; 37(40):14222-9. PubMed ID: 9760260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LP-X in cholestasis.
    Tanno H; Fay O; Palazzi J; Pedrana R; Yäger E; Roncoroni M
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):289-91. PubMed ID: 173123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum superoxide dismutase activity in acute and chronic paediatric liver diseases.
    El-Shabrawi MH; Kamal NM; Halawa FA; El-Guindi MA; Sobhy GA
    Arab J Gastroenterol; 2014 Jun; 15(2):72-5. PubMed ID: 25097050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum copper, zinc, ceruloplasmin and superoxide dismutase in Thai overweight and obese.
    Tungtrongchitr R; Pongpaew P; Phonrat B; Tungtrongchitr A; Viroonudomphol D; Vudhivai N; Schelp FP
    J Med Assoc Thai; 2003 Jun; 86(6):543-51. PubMed ID: 12924803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipid peroxidation and antioxidative protection in patients with coronary heart disease].
    Belaia OL; Artamoshina NE; Kalmykova VI; Kuropteva ZV; Baĭder LM
    Klin Med (Mosk); 2009; 87(5):21-4. PubMed ID: 19565822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The activity of cholesterol esterase and ceruloplasmin are inversely related in the serum of men with atherosclerosis obliterans.
    Pioruńska-Stolzmann M; Iskra M; Majewski W
    Med Sci Monit; 2001; 7(5):940-5. PubMed ID: 11535939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The clinico-pathogenetic variants of cholestasis in different liver diseases].
    Ivashkin VT; Ivlev AS; Pliusnin SV; Vasil'ev AP
    Ter Arkh; 1992; 64(2):6-9. PubMed ID: 1509386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.